The FDA’s Cardiovascular and Renal Drugs Advisory Committee once again turned down the supplemental new drug application for an acute coronary syndrome indication for Johnson & Johnson’s Xarelto...
For Obama, NSA review a quest to regain public trust in surveillance operations WASHINGTON (AP) — Faced with Edward Snowden's first leaks about the government's sweeping surveillance...
Will 2014 be the year we trade in our credit cards and abandon our wallets in favor of virtual currencies? If you follow the recent hype surrounding bitcoin, the trendiest of the new crop of digital...
By Michael Evans and Jennifer Knight Your plans for the New Year call for growing your company’s revenue in 2014, but where will your increased sales come from — a larger salesforce, new markets, or...
I met Melanie Feldman in December 2012 when she was compiling stories for BOLD: Get Noticed and Get Hired. Partly inspired by an article I wrote for Forbes titled “Success Stories About People...
HHS cybersecurity chief says health care website tests didn't follow security 'best practices' WASHINGTON (AP) — The top cybersecurity officer for the Health and Human Services...
The FDA’s Cardiovascular and Renal Drugs Advisory Committee voted 10-1 in favor of approval for vorapaxar, Merck's novel thrombin receptor antagonist. The “roller coaster ride” cliché might have...
The Wild West has become a popular metaphor for the unregulated Bitcoin market. Like in old cowboy films, the world of Bitcoin has not only miners and modern a gold rush, but the requisite intrigue...
The Beyerdynamic DX 160 iE are smaller than the last Beyerdynamic headphone I reviewed. A lot smaller, since those were big open-back over-ears. Perhaps best known for those big over-ears, and on-ear...
At the Mobile World Congress in Barcelona, Feb, 24, a joint venture that appears to be somewhat covert in nature between Silent Circle and Geeksphone, will launch a new ultra secure smartphone that...